Pharma Journalist -

Samsung Biologics has announced an agreement to acquire Swiss contract development and manufacturing organization (CDMO) PolyPeptide Group AG in an all-cash transaction valued at…
Read More...

Halozyme Therapeutics and Incyte have entered into a global collaboration and licensing agreement to develop additional subcutaneous formulations of Incyte's investigational blood…
Read More...

Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment of a second NVIDIA DGX SuperPOD, strengthening its efforts to…
Read More...

Novo Nordisk has filed a lawsuit against Eli Lilly and Company and Lilly USA in the United States, alleging that the pharmaceutical giant's advertising for its blockbuster diabetes and…
Read More...

The European Commission has approved an expanded indication for Crysvita (burosumab), allowing the therapy to be used in infants aged one month to one year with X-linked…
Read More...

Organon and Samsung Bioepis have expanded their long-standing partnership to bring a new biosimilar medicine to patients in Australia, strengthening their efforts to improve access to…
Read More...

Telix Pharmaceuticals has officially opened a new multi-million-dollar radiopharmaceutical research, manufacturing and treatment facility in Melbourne, Australia, marking a major step…
Read More...

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved LIPFENDRA (enlicitide) 20 mg tablets for adults…
Read More...

Novartis has announced that the US Food and Drug Administration (FDA) has granted traditional approval to Fabhalta (iptacopan) for adults with primary immunoglobulin A nephropathy…
Read More...

Novo Nordisk has announced that the European Commission (EC) has approved Wegovy® pill (oral semaglutide 25 mg) for the treatment of adults living with obesity or overweight with at…
Read More...